US Stock MarketDetailed Quotes

LEXX Lexaria Bioscience

Watchlist

3.1500
+0.0100+0.32%

Close May 17 16:00 ET

3.0000
-0.1500-4.76%

Post 18:11 ET

49.78MMarket Cap-4701P/E (TTM)

Lexaria Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Feb 29, 2024

(Q1)Nov 30, 2023

(FY)Aug 31, 2023

(Q4)Aug 31, 2023

(Q3)May 31, 2023

(Q2)Feb 28, 2023

(Q1)Nov 30, 2022

(FY)Aug 31, 2022

(Q4)Aug 31, 2022

(Q3)May 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

49.55%-619.61K

5.11%-1.18M

-20.53%-5.88M

-37.83%-1.62M

-41.84%-1.79M

3.84%-1.23M

-6.77%-1.25M

-22.30%-4.88M

-5.79%-1.18M

-8.85%-1.26M

Net income from continuing operations

50.20%-652.73K

33.02%-1.19M

9.09%-6.71M

17.46%-1.25M

1.44%-2.38M

9.53%-1.31M

11.69%-1.77M

-76.38%-7.38M

-14.23%-1.51M

5.77%-2.42M

Operating gains losses

----

98.92%-7.93K

----

Depreciation and amortization

-35.58%15.93K

16.37%28.78K

41.55%145.4K

186.79%70.93K

4.68%25.01K

-5.48%24.73K

-11.46%24.73K

-30.41%102.72K

-61.24%24.73K

-14.45%23.89K

Other non cash items

-9.12%18.3K

878.43%1.99K

-96.48%43.79K

-98.21%10.95K

-95.83%12.96K

-93.52%20.14K

-102.33%-255

1,238.68%1.24M

917.09%610.95K

2,740.23%310.95K

Change In working capital

-137.46%-9.35K

-138.10%-134.55K

140.76%143.26K

-53.81%-714.85K

181.14%480.04K

123.36%24.96K

614.39%353.11K

-653.28%-351.48K

-10,594.41%-464.78K

-0.29%170.75K

-Change in receivables

24.87%186.71K

-382.68%-408.05K

119.30%26.54K

93.69%-2.96K

-148.19%-35.49K

431.47%149.53K

29.03%-84.54K

-172.52%-137.49K

-124.60%-46.92K

8.05%73.65K

-Change in inventory

--0

2,276.30%43.07K

--0

216.44%9.36K

171.71%2.92K

956.66%30.79K

-102.08%-1.98K

-68.70%7.22K

-109.04%-8.04K

-Change in prepaid assets

-126.98%-134.49K

30.99%414.47K

111.64%29.98K

119.78%82.96K

-579.71%-310.15K

-488.21%-59.25K

285.74%316.42K

-87.75%-257.51K

-181.86%-419.45K

-66.55%64.65K

-Change in payables and accrued expense

16.24%-43.65K

-255.87%-140.97K

94.48%88.49K

-13,829.01%-783.65K

1,959.61%833.81K

28.56%-52.12K

8.19%90.44K

214.68%45.5K

91.88%-5.63K

122.73%40.48K

-Change in other current liabilities

----

---44.81K

---11.2K

---13.21K

----

--0

Cash from discontinued investing activities

Operating cash flow

49.55%-619.61K

5.11%-1.18M

-20.53%-5.88M

-37.83%-1.62M

-41.84%-1.79M

3.84%-1.23M

-6.77%-1.25M

-22.30%-4.88M

-5.79%-1.18M

-8.85%-1.26M

Investing cash flow

Cash flow from continuing investing activities

-74.37%-56.99K

-14.88%-40.03K

6.11%-169.61K

-36.75%-68.44K

11.35%-33.65K

5.05%-32.68K

40.15%-34.84K

-193.17%-180.64K

-2,502,150.00%-50.05K

46.33%-37.96K

Net PPE purchase and sale

--0

31.40%-33.75K

--0

---13.25K

51.62%-20.5K

---49.19K

---4

---6.81K

Net intangibles purchase and sale

-193.22%-56.99K

-179.08%-40.03K

-3.36%-135.86K

-36.76%-68.44K

-8.04%-33.65K

43.54%-19.44K

9.46%-14.34K

-65.36%-131.45K

---50.04K

55.97%-31.14K

Cash from discontinued investing activities

Investing cash flow

-74.37%-56.99K

-14.88%-40.03K

6.11%-169.61K

-36.75%-68.44K

11.35%-33.65K

5.05%-32.68K

40.15%-34.84K

-193.17%-180.64K

-2,502,150.00%-50.05K

46.33%-37.96K

Financing cash flow

Cash flow from continuing financing activities

3.45M

1.82M

3,664.42%1.59M

-986.01%-121.69K

15,375.06%1.71M

-100.33%-44.6K

-100.28%-11.21K

-1.98%-11.2K

Net issuance payments of debt

----

--0

----

33.13%-44.6K

-6.02%-11.21K

-1.98%-11.2K

Net common stock issuance

--2.96M

--1.25M

--1.59M

---121.69K

--1.71M

--0

----

Proceeds from stock option exercised by employees

--491.82K

--571.65K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

--3.45M

--1.82M

3,664.42%1.59M

-986.01%-121.69K

15,375.06%1.71M

--0

-100.33%-44.6K

-100.28%-11.21K

-1.98%-11.2K

Net cash flow

Beginning cash position

-56.89%1.95M

-76.74%1.35M

-46.75%5.81M

-55.13%3.16M

-60.86%3.27M

-53.18%4.53M

-46.75%5.81M

743.89%10.92M

-13.04%7.05M

-10.57%8.36M

Current changes in cash

320.17%2.78M

146.69%597.69K

12.61%-4.46M

-46.37%-1.81M

91.73%-108.2K

4.68%-1.26M

-3.61%-1.28M

-153.04%-5.1M

-144.06%-1.24M

-5.64%-1.31M

Effect of exchange rate changes

---25K

--4.37K

----

--0

----

End cash Position

43.80%4.71M

-56.89%1.95M

-76.74%1.35M

-55.13%3.16M

-60.86%3.27M

-53.18%4.53M

-46.75%5.81M

-13.04%7.05M

Free cash flow

46.34%-676.6K

4.57%-1.22M

-19.58%-6.05M

-37.78%-1.69M

-40.28%-1.82M

3.87%-1.26M

-4.54%-1.28M

-24.35%-5.06M

-10.29%-1.23M

-5.67%-1.3M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q2)Feb 29, 2024	(Q1)Nov 30, 2023	(FY)Aug 31, 2023	(Q4)Aug 31, 2023	(Q3)May 31, 2023	(Q2)Feb 28, 2023	(Q1)Nov 30, 2022	(FY)Aug 31, 2022	(Q4)Aug 31, 2022	(Q3)May 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	49.55%-619.61K	5.11%-1.18M	-20.53%-5.88M	-37.83%-1.62M	-41.84%-1.79M	3.84%-1.23M	-6.77%-1.25M	-22.30%-4.88M	-5.79%-1.18M	-8.85%-1.26M
Net income from continuing operations	50.20%-652.73K	33.02%-1.19M	9.09%-6.71M	17.46%-1.25M	1.44%-2.38M	9.53%-1.31M	11.69%-1.77M	-76.38%-7.38M	-14.23%-1.51M	5.77%-2.42M
Operating gains losses	----	----	----	----	----	----	----	98.92%-7.93K	----	----
Depreciation and amortization	-35.58%15.93K	16.37%28.78K	41.55%145.4K	186.79%70.93K	4.68%25.01K	-5.48%24.73K	-11.46%24.73K	-30.41%102.72K	-61.24%24.73K	-14.45%23.89K
Other non cash items	-9.12%18.3K	878.43%1.99K	-96.48%43.79K	-98.21%10.95K	-95.83%12.96K	-93.52%20.14K	-102.33%-255	1,238.68%1.24M	917.09%610.95K	2,740.23%310.95K
Change In working capital	-137.46%-9.35K	-138.10%-134.55K	140.76%143.26K	-53.81%-714.85K	181.14%480.04K	123.36%24.96K	614.39%353.11K	-653.28%-351.48K	-10,594.41%-464.78K	-0.29%170.75K
-Change in receivables	24.87%186.71K	-382.68%-408.05K	119.30%26.54K	93.69%-2.96K	-148.19%-35.49K	431.47%149.53K	29.03%-84.54K	-172.52%-137.49K	-124.60%-46.92K	8.05%73.65K
-Change in inventory	--0	--0	2,276.30%43.07K	--0	216.44%9.36K	171.71%2.92K	956.66%30.79K	-102.08%-1.98K	-68.70%7.22K	-109.04%-8.04K
-Change in prepaid assets	-126.98%-134.49K	30.99%414.47K	111.64%29.98K	119.78%82.96K	-579.71%-310.15K	-488.21%-59.25K	285.74%316.42K	-87.75%-257.51K	-181.86%-419.45K	-66.55%64.65K
-Change in payables and accrued expense	16.24%-43.65K	-255.87%-140.97K	94.48%88.49K	-13,829.01%-783.65K	1,959.61%833.81K	28.56%-52.12K	8.19%90.44K	214.68%45.5K	91.88%-5.63K	122.73%40.48K
-Change in other current liabilities	----	----	---44.81K	---11.2K	---13.21K	----	----	--0	--0	--0
Cash from discontinued investing activities
Operating cash flow	49.55%-619.61K	5.11%-1.18M	-20.53%-5.88M	-37.83%-1.62M	-41.84%-1.79M	3.84%-1.23M	-6.77%-1.25M	-22.30%-4.88M	-5.79%-1.18M	-8.85%-1.26M
Investing cash flow
Cash flow from continuing investing activities	-74.37%-56.99K	-14.88%-40.03K	6.11%-169.61K	-36.75%-68.44K	11.35%-33.65K	5.05%-32.68K	40.15%-34.84K	-193.17%-180.64K	-2,502,150.00%-50.05K	46.33%-37.96K
Net PPE purchase and sale	--0	--0	31.40%-33.75K	--0	--0	---13.25K	51.62%-20.5K	---49.19K	---4	---6.81K
Net intangibles purchase and sale	-193.22%-56.99K	-179.08%-40.03K	-3.36%-135.86K	-36.76%-68.44K	-8.04%-33.65K	43.54%-19.44K	9.46%-14.34K	-65.36%-131.45K	---50.04K	55.97%-31.14K
Cash from discontinued investing activities
Investing cash flow	-74.37%-56.99K	-14.88%-40.03K	6.11%-169.61K	-36.75%-68.44K	11.35%-33.65K	5.05%-32.68K	40.15%-34.84K	-193.17%-180.64K	-2,502,150.00%-50.05K	46.33%-37.96K
Financing cash flow
Cash flow from continuing financing activities	3.45M	1.82M	3,664.42%1.59M	-986.01%-121.69K	15,375.06%1.71M	0	0	-100.33%-44.6K	-100.28%-11.21K	-1.98%-11.2K
Net issuance payments of debt	----	----	--0	--0	----	----	----	33.13%-44.6K	-6.02%-11.21K	-1.98%-11.2K
Net common stock issuance	--2.96M	--1.25M	--1.59M	---121.69K	--1.71M	--0	--0	--0	--0	----
Proceeds from stock option exercised by employees	--491.82K	--571.65K	----	----	----	--0	--0	----	----	----
Cash from discontinued financing activities
Financing cash flow	--3.45M	--1.82M	3,664.42%1.59M	-986.01%-121.69K	15,375.06%1.71M	--0	--0	-100.33%-44.6K	-100.28%-11.21K	-1.98%-11.2K
Net cash flow
Beginning cash position	-56.89%1.95M	-76.74%1.35M	-46.75%5.81M	-55.13%3.16M	-60.86%3.27M	-53.18%4.53M	-46.75%5.81M	743.89%10.92M	-13.04%7.05M	-10.57%8.36M
Current changes in cash	320.17%2.78M	146.69%597.69K	12.61%-4.46M	-46.37%-1.81M	91.73%-108.2K	4.68%-1.26M	-3.61%-1.28M	-153.04%-5.1M	-144.06%-1.24M	-5.64%-1.31M
Effect of exchange rate changes	---25K	--4.37K	----	----	----	----	--0	----	----	----
End cash Position	43.80%4.71M	-56.89%1.95M	-76.74%1.35M	-76.74%1.35M	-55.13%3.16M	-60.86%3.27M	-53.18%4.53M	-46.75%5.81M	-46.75%5.81M	-13.04%7.05M
Free cash flow	46.34%-676.6K	4.57%-1.22M	-19.58%-6.05M	-37.78%-1.69M	-40.28%-1.82M	3.87%-1.26M	-4.54%-1.28M	-24.35%-5.06M	-10.29%-1.23M	-5.67%-1.3M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall